世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い
 静脈内投与プライマリーセット-世界市場シェア・ランキング、全体売上高・需要予測 2025-2031IV Administration Primary Set- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031 静脈内投与プライマリーセットの世界市場は、2024年には100万米ドルと推定され、2031年には100万米ドルに再調整され、予測期間2025-2031年の年平均成長率は%になると予測されている。 世界の医薬品市場は2022... もっと見る
※当ページの内容はウェブ更新時の情報です。 
サマリー静脈内投与プライマリーセットの世界市場は、2024年には100万米ドルと推定され、2031年には100万米ドルに再調整され、予測期間2025-2031年の年平均成長率は%になると予測されている。世界の医薬品市場は2022年に1,475億米ドルとなり、今後6年間のCAGRは5％で成長する。医薬品市場には、化学医薬品と生物学的製剤が含まれる。生物製剤は2022年に3810億米ドルになると予想されている。これに対し、化学医薬品市場は2018年の1,050億米ドルから2022年には1,090億米ドルに増加すると推定されている。医薬品市場の要因としては、医療需要の増加、技術の進歩、慢性疾患の有病率の上昇、医薬品製造分野の開発に対する民間＆政府機関からの資金提供の増加、医薬品の研究開発活動の活発化などが挙げられる。しかし、厳しい規制、研究開発費の高騰、特許切れといった課題にも直面している。企業は、市場での競争力を維持し、必要とする患者に確実に製品を届けるために、継続的に技術革新を行い、こうした課題に適応していく必要がある。さらに、COVID-19の大流行は、ワクチン開発とサプライチェーン・マネジメントの重要性を浮き彫りにし、製薬企業が公衆衛生の新たなニーズに機敏に対応する必要性をさらに強調している。 本レポートでは、点滴静注用プライマリセットの世界市場について、地域別・国別、タイプ別、用途別の分析とともに、総販売量、販売収益、価格、主要企業の市場シェア、ランキングに焦点を当て、包括的に紹介することを目的としています。 点滴静注用プライマリーセットの市場規模、推計、予測は、2024年を基準年として、2020年から2031年までの期間の履歴データと予測データとともに、販売台数（K単位）と販売収益（百万ドル）で提供されます。定量的および定性的な分析により、読者が事業/成長戦略を策定し、市場競争状況を評価し、現在の市場での地位を分析し、静脈内投与プライマリセットに関する情報に基づいたビジネス上の意思決定を行うのに役立ちます。 市場区分 企業別 BD B.ブラウン アムシーノ 3M バクスターインターナショナル ICUメディカル スミスメディカル バイエル ザイノメディカル アドバンスト・メディカル・システムズ MPSメディカル SB川澄 メドソースラボ エイタングループ コーダンUSコーポレーション メドテック・メディカル タイプ別セグメント 1ミクロン未満 1～200ミクロン 200ミクロン以上 用途別セグメント 病院 クリニック その他 地域別 北米 米国 カナダ アジア太平洋 中国 日本 韓国 東南アジア インド オーストラリア その他のアジア太平洋地域 欧州 ドイツ フランス 英国 イタリア オランダ 北欧諸国 その他のヨーロッパ ラテンアメリカ メキシコ ブラジル その他のラテンアメリカ 中東・アフリカ トルコ サウジアラビア アラブ首長国連邦 その他のMEA 各章の概要 第1章： レポートの対象範囲、世界の総市場規模（金額、数量、価格）を紹介します。また本章では、市場ダイナミクス、市場の最新動向、市場の促進要因と制限要因、業界メーカーが直面する課題とリスク、業界の関連政策の分析を提供します。 第2章：静脈内投与プライマリーセットメーカーの競争環境、価格、売上高、市場シェア、最新の開発計画、合併・買収情報などを詳細に分析。 第3章：各種市場セグメントをタイプ別に分析し、各市場セグメントの市場規模と発展可能性を網羅し、読者が各市場セグメントのブルーオーシャン市場を見つけやすくします。 第4章：アプリケーション別の様々な市場セグメントの分析を提供し、各市場セグメントの市場規模と発展の可能性をカバーし、読者が異なる川下市場でのブルーオーシャン市場を見つけるのに役立ちます。 第5章：地域レベルでの静脈内投与プライマリーセットの売上高、収益。各地域の市場規模と発展可能性を定量的に分析し、世界各国の市場発展、今後の発展展望、市場空間、市場規模を紹介しています。 第6章：国別の静脈内投与プライマリーセットの販売、収益。各国・地域のタイプ別、用途別のシグメイトデータを提供。 第7章：主要企業のプロファイルを提供し、製品の売上高、収益、価格、売上総利益率、製品紹介、最近の開発など、市場の主要企業の基本的な状況を詳細に紹介します。 第8章：産業の上流と下流を含む産業チェーンの分析。 第9章：結論 目次1 Market Overview1.1 IV Administration Primary Set Product Introduction 1.2 Global IV Administration Primary Set Market Size Forecast 1.2.1 Global IV Administration Primary Set Sales Value (2020-2031) 1.2.2 Global IV Administration Primary Set Sales Volume (2020-2031) 1.2.3 Global IV Administration Primary Set Sales Price (2020-2031) 1.3 IV Administration Primary Set Market Trends & Drivers 1.3.1 IV Administration Primary Set Industry Trends 1.3.2 IV Administration Primary Set Market Drivers & Opportunity 1.3.3 IV Administration Primary Set Market Challenges 1.3.4 IV Administration Primary Set Market Restraints 1.4 Assumptions and Limitations 1.5 Study Objectives 1.6 Years Considered 2 Competitive Analysis by Company 2.1 Global IV Administration Primary Set Players Revenue Ranking (2024) 2.2 Global IV Administration Primary Set Revenue by Company (2020-2025) 2.3 Global IV Administration Primary Set Players Sales Volume Ranking (2024) 2.4 Global IV Administration Primary Set Sales Volume by Company Players (2020-2025) 2.5 Global IV Administration Primary Set Average Price by Company (2020-2025) 2.6 Key Manufacturers IV Administration Primary Set Manufacturing Base and Headquarters 2.7 Key Manufacturers IV Administration Primary Set Product Offered 2.8 Key Manufacturers Time to Begin Mass Production of IV Administration Primary Set 2.9 IV Administration Primary Set Market Competitive Analysis 2.9.1 IV Administration Primary Set Market Concentration Rate (2020-2025) 2.9.2 Global 5 and 10 Largest Manufacturers by IV Administration Primary Set Revenue in 2024 2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in IV Administration Primary Set as of 2024) 2.10 Mergers & Acquisitions, Expansion 3 Segmentation by Type 3.1 Introduction by Type 3.1.1 Less Than 1 Micron 3.1.2 1 - 200 Micron 3.1.3 More Than 200 Micron 3.2 Global IV Administration Primary Set Sales Value by Type 3.2.1 Global IV Administration Primary Set Sales Value by Type (2020 VS 2024 VS 2031) 3.2.2 Global IV Administration Primary Set Sales Value, by Type (2020-2031) 3.2.3 Global IV Administration Primary Set Sales Value, by Type (%) (2020-2031) 3.3 Global IV Administration Primary Set Sales Volume by Type 3.3.1 Global IV Administration Primary Set Sales Volume by Type (2020 VS 2024 VS 2031) 3.3.2 Global IV Administration Primary Set Sales Volume, by Type (2020-2031) 3.3.3 Global IV Administration Primary Set Sales Volume, by Type (%) (2020-2031) 3.4 Global IV Administration Primary Set Average Price by Type (2020-2031) 4 Segmentation by Application 4.1 Introduction by Application 4.1.1 Hospitals 4.1.2 Clinics 4.1.3 Other 4.2 Global IV Administration Primary Set Sales Value by Application 4.2.1 Global IV Administration Primary Set Sales Value by Application (2020 VS 2024 VS 2031) 4.2.2 Global IV Administration Primary Set Sales Value, by Application (2020-2031) 4.2.3 Global IV Administration Primary Set Sales Value, by Application (%) (2020-2031) 4.3 Global IV Administration Primary Set Sales Volume by Application 4.3.1 Global IV Administration Primary Set Sales Volume by Application (2020 VS 2024 VS 2031) 4.3.2 Global IV Administration Primary Set Sales Volume, by Application (2020-2031) 4.3.3 Global IV Administration Primary Set Sales Volume, by Application (%) (2020-2031) 4.4 Global IV Administration Primary Set Average Price by Application (2020-2031) 5 Segmentation by Region 5.1 Global IV Administration Primary Set Sales Value by Region 5.1.1 Global IV Administration Primary Set Sales Value by Region: 2020 VS 2024 VS 2031 5.1.2 Global IV Administration Primary Set Sales Value by Region (2020-2025) 5.1.3 Global IV Administration Primary Set Sales Value by Region (2026-2031) 5.1.4 Global IV Administration Primary Set Sales Value by Region (%), (2020-2031) 5.2 Global IV Administration Primary Set Sales Volume by Region 5.2.1 Global IV Administration Primary Set Sales Volume by Region: 2020 VS 2024 VS 2031 5.2.2 Global IV Administration Primary Set Sales Volume by Region (2020-2025) 5.2.3 Global IV Administration Primary Set Sales Volume by Region (2026-2031) 5.2.4 Global IV Administration Primary Set Sales Volume by Region (%), (2020-2031) 5.3 Global IV Administration Primary Set Average Price by Region (2020-2031) 5.4 North America 5.4.1 North America IV Administration Primary Set Sales Value, 2020-2031 5.4.2 North America IV Administration Primary Set Sales Value by Country (%), 2024 VS 2031 5.5 Europe 5.5.1 Europe IV Administration Primary Set Sales Value, 2020-2031 5.5.2 Europe IV Administration Primary Set Sales Value by Country (%), 2024 VS 2031 5.6 Asia Pacific 5.6.1 Asia Pacific IV Administration Primary Set Sales Value, 2020-2031 5.6.2 Asia Pacific IV Administration Primary Set Sales Value by Region (%), 2024 VS 2031 5.7 South America 5.7.1 South America IV Administration Primary Set Sales Value, 2020-2031 5.7.2 South America IV Administration Primary Set Sales Value by Country (%), 2024 VS 2031 5.8 Middle East & Africa 5.8.1 Middle East & Africa IV Administration Primary Set Sales Value, 2020-2031 5.8.2 Middle East & Africa IV Administration Primary Set Sales Value by Country (%), 2024 VS 2031 6 Segmentation by Key Countries/Regions 6.1 Key Countries/Regions IV Administration Primary Set Sales Value Growth Trends, 2020 VS 2024 VS 2031 6.2 Key Countries/Regions IV Administration Primary Set Sales Value 6.2.1 Key Countries/Regions IV Administration Primary Set Sales Value, 2020-2031 6.2.2 Key Countries/Regions IV Administration Primary Set Sales Volume, 2020-2031 6.3 United States 6.3.1 United States IV Administration Primary Set Sales Value, 2020-2031 6.3.2 United States IV Administration Primary Set Sales Value by Type (%), 2024 VS 2031 6.3.3 United States IV Administration Primary Set Sales Value by Application, 2024 VS 2031 6.4 Europe 6.4.1 Europe IV Administration Primary Set Sales Value, 2020-2031 6.4.2 Europe IV Administration Primary Set Sales Value by Type (%), 2024 VS 2031 6.4.3 Europe IV Administration Primary Set Sales Value by Application, 2024 VS 2031 6.5 China 6.5.1 China IV Administration Primary Set Sales Value, 2020-2031 6.5.2 China IV Administration Primary Set Sales Value by Type (%), 2024 VS 2031 6.5.3 China IV Administration Primary Set Sales Value by Application, 2024 VS 2031 6.6 Japan 6.6.1 Japan IV Administration Primary Set Sales Value, 2020-2031 6.6.2 Japan IV Administration Primary Set Sales Value by Type (%), 2024 VS 2031 6.6.3 Japan IV Administration Primary Set Sales Value by Application, 2024 VS 2031 6.7 South Korea 6.7.1 South Korea IV Administration Primary Set Sales Value, 2020-2031 6.7.2 South Korea IV Administration Primary Set Sales Value by Type (%), 2024 VS 2031 6.7.3 South Korea IV Administration Primary Set Sales Value by Application, 2024 VS 2031 6.8 Southeast Asia 6.8.1 Southeast Asia IV Administration Primary Set Sales Value, 2020-2031 6.8.2 Southeast Asia IV Administration Primary Set Sales Value by Type (%), 2024 VS 2031 6.8.3 Southeast Asia IV Administration Primary Set Sales Value by Application, 2024 VS 2031 6.9 India 6.9.1 India IV Administration Primary Set Sales Value, 2020-2031 6.9.2 India IV Administration Primary Set Sales Value by Type (%), 2024 VS 2031 6.9.3 India IV Administration Primary Set Sales Value by Application, 2024 VS 2031 7 Company Profiles 7.1 BD 7.1.1 BD Company Information 7.1.2 BD Introduction and Business Overview 7.1.3 BD IV Administration Primary Set Sales, Revenue, Price and Gross Margin (2020-2025) 7.1.4 BD IV Administration Primary Set Product Offerings 7.1.5 BD Recent Development 7.2 B. Braun 7.2.1 B. Braun Company Information 7.2.2 B. Braun Introduction and Business Overview 7.2.3 B. Braun IV Administration Primary Set Sales, Revenue, Price and Gross Margin (2020-2025) 7.2.4 B. Braun IV Administration Primary Set Product Offerings 7.2.5 B. Braun Recent Development 7.3 Amsino 7.3.1 Amsino Company Information 7.3.2 Amsino Introduction and Business Overview 7.3.3 Amsino IV Administration Primary Set Sales, Revenue, Price and Gross Margin (2020-2025) 7.3.4 Amsino IV Administration Primary Set Product Offerings 7.3.5 Amsino Recent Development 7.4 3M 7.4.1 3M Company Information 7.4.2 3M Introduction and Business Overview 7.4.3 3M IV Administration Primary Set Sales, Revenue, Price and Gross Margin (2020-2025) 7.4.4 3M IV Administration Primary Set Product Offerings 7.4.5 3M Recent Development 7.5 Baxter International 7.5.1 Baxter International Company Information 7.5.2 Baxter International Introduction and Business Overview 7.5.3 Baxter International IV Administration Primary Set Sales, Revenue, Price and Gross Margin (2020-2025) 7.5.4 Baxter International IV Administration Primary Set Product Offerings 7.5.5 Baxter International Recent Development 7.6 ICU Medical 7.6.1 ICU Medical Company Information 7.6.2 ICU Medical Introduction and Business Overview 7.6.3 ICU Medical IV Administration Primary Set Sales, Revenue, Price and Gross Margin (2020-2025) 7.6.4 ICU Medical IV Administration Primary Set Product Offerings 7.6.5 ICU Medical Recent Development 7.7 Smiths Medical 7.7.1 Smiths Medical Company Information 7.7.2 Smiths Medical Introduction and Business Overview 7.7.3 Smiths Medical IV Administration Primary Set Sales, Revenue, Price and Gross Margin (2020-2025) 7.7.4 Smiths Medical IV Administration Primary Set Product Offerings 7.7.5 Smiths Medical Recent Development 7.8 Bayer 7.8.1 Bayer Company Information 7.8.2 Bayer Introduction and Business Overview 7.8.3 Bayer IV Administration Primary Set Sales, Revenue, Price and Gross Margin (2020-2025) 7.8.4 Bayer IV Administration Primary Set Product Offerings 7.8.5 Bayer Recent Development 7.9 Zyno Medical 7.9.1 Zyno Medical Company Information 7.9.2 Zyno Medical Introduction and Business Overview 7.9.3 Zyno Medical IV Administration Primary Set Sales, Revenue, Price and Gross Margin (2020-2025) 7.9.4 Zyno Medical IV Administration Primary Set Product Offerings 7.9.5 Zyno Medical Recent Development 7.10 Advanced Medical Systems 7.10.1 Advanced Medical Systems Company Information 7.10.2 Advanced Medical Systems Introduction and Business Overview 7.10.3 Advanced Medical Systems IV Administration Primary Set Sales, Revenue, Price and Gross Margin (2020-2025) 7.10.4 Advanced Medical Systems IV Administration Primary Set Product Offerings 7.10.5 Advanced Medical Systems Recent Development 7.11 MPS Medical 7.11.1 MPS Medical Company Information 7.11.2 MPS Medical Introduction and Business Overview 7.11.3 MPS Medical IV Administration Primary Set Sales, Revenue, Price and Gross Margin (2020-2025) 7.11.4 MPS Medical IV Administration Primary Set Product Offerings 7.11.5 MPS Medical Recent Development 7.12 SB Kawasumi 7.12.1 SB Kawasumi Company Information 7.12.2 SB Kawasumi Introduction and Business Overview 7.12.3 SB Kawasumi IV Administration Primary Set Sales, Revenue, Price and Gross Margin (2020-2025) 7.12.4 SB Kawasumi IV Administration Primary Set Product Offerings 7.12.5 SB Kawasumi Recent Development 7.13 MedSource Labs 7.13.1 MedSource Labs Company Information 7.13.2 MedSource Labs Introduction and Business Overview 7.13.3 MedSource Labs IV Administration Primary Set Sales, Revenue, Price and Gross Margin (2020-2025) 7.13.4 MedSource Labs IV Administration Primary Set Product Offerings 7.13.5 MedSource Labs Recent Development 7.14 Eitan Group 7.14.1 Eitan Group Company Information 7.14.2 Eitan Group Introduction and Business Overview 7.14.3 Eitan Group IV Administration Primary Set Sales, Revenue, Price and Gross Margin (2020-2025) 7.14.4 Eitan Group IV Administration Primary Set Product Offerings 7.14.5 Eitan Group Recent Development 7.15 CODAN US Corporation 7.15.1 CODAN US Corporation Company Information 7.15.2 CODAN US Corporation Introduction and Business Overview 7.15.3 CODAN US Corporation IV Administration Primary Set Sales, Revenue, Price and Gross Margin (2020-2025) 7.15.4 CODAN US Corporation IV Administration Primary Set Product Offerings 7.15.5 CODAN US Corporation Recent Development 7.16 Medtec Medical 7.16.1 Medtec Medical Company Information 7.16.2 Medtec Medical Introduction and Business Overview 7.16.3 Medtec Medical IV Administration Primary Set Sales, Revenue, Price and Gross Margin (2020-2025) 7.16.4 Medtec Medical IV Administration Primary Set Product Offerings 7.16.5 Medtec Medical Recent Development 8 Industry Chain Analysis 8.1 IV Administration Primary Set Industrial Chain 8.2 IV Administration Primary Set Upstream Analysis 8.2.1 Key Raw Materials 8.2.2 Raw Materials Key Suppliers 8.2.3 Manufacturing Cost Structure 8.3 Midstream Analysis 8.4 Downstream Analysis (Customers Analysis) 8.5 Sales Model and Sales Channels 8.5.1 IV Administration Primary Set Sales Model 8.5.2 Sales Channel 8.5.3 IV Administration Primary Set Distributors 9 Research Findings and Conclusion 10 Appendix 10.1 Research Methodology 10.1.1 Methodology/Research Approach 10.1.1.1 Research Programs/Design 10.1.1.2 Market Size Estimation 10.1.1.3 Market Breakdown and Data Triangulation 10.1.2 Data Source 10.1.2.1 Secondary Sources 10.1.2.2 Primary Sources 10.2 Author Details 10.3 Disclaimer
SummaryThe global market for IV Administration Primary Set was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031. Table of Contents1 Market Overview1.1 IV Administration Primary Set Product Introduction 1.2 Global IV Administration Primary Set Market Size Forecast 1.2.1 Global IV Administration Primary Set Sales Value (2020-2031) 1.2.2 Global IV Administration Primary Set Sales Volume (2020-2031) 1.2.3 Global IV Administration Primary Set Sales Price (2020-2031) 1.3 IV Administration Primary Set Market Trends & Drivers 1.3.1 IV Administration Primary Set Industry Trends 1.3.2 IV Administration Primary Set Market Drivers & Opportunity 1.3.3 IV Administration Primary Set Market Challenges 1.3.4 IV Administration Primary Set Market Restraints 1.4 Assumptions and Limitations 1.5 Study Objectives 1.6 Years Considered 2 Competitive Analysis by Company 2.1 Global IV Administration Primary Set Players Revenue Ranking (2024) 2.2 Global IV Administration Primary Set Revenue by Company (2020-2025) 2.3 Global IV Administration Primary Set Players Sales Volume Ranking (2024) 2.4 Global IV Administration Primary Set Sales Volume by Company Players (2020-2025) 2.5 Global IV Administration Primary Set Average Price by Company (2020-2025) 2.6 Key Manufacturers IV Administration Primary Set Manufacturing Base and Headquarters 2.7 Key Manufacturers IV Administration Primary Set Product Offered 2.8 Key Manufacturers Time to Begin Mass Production of IV Administration Primary Set 2.9 IV Administration Primary Set Market Competitive Analysis 2.9.1 IV Administration Primary Set Market Concentration Rate (2020-2025) 2.9.2 Global 5 and 10 Largest Manufacturers by IV Administration Primary Set Revenue in 2024 2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in IV Administration Primary Set as of 2024) 2.10 Mergers & Acquisitions, Expansion 3 Segmentation by Type 3.1 Introduction by Type 3.1.1 Less Than 1 Micron 3.1.2 1 - 200 Micron 3.1.3 More Than 200 Micron 3.2 Global IV Administration Primary Set Sales Value by Type 3.2.1 Global IV Administration Primary Set Sales Value by Type (2020 VS 2024 VS 2031) 3.2.2 Global IV Administration Primary Set Sales Value, by Type (2020-2031) 3.2.3 Global IV Administration Primary Set Sales Value, by Type (%) (2020-2031) 3.3 Global IV Administration Primary Set Sales Volume by Type 3.3.1 Global IV Administration Primary Set Sales Volume by Type (2020 VS 2024 VS 2031) 3.3.2 Global IV Administration Primary Set Sales Volume, by Type (2020-2031) 3.3.3 Global IV Administration Primary Set Sales Volume, by Type (%) (2020-2031) 3.4 Global IV Administration Primary Set Average Price by Type (2020-2031) 4 Segmentation by Application 4.1 Introduction by Application 4.1.1 Hospitals 4.1.2 Clinics 4.1.3 Other 4.2 Global IV Administration Primary Set Sales Value by Application 4.2.1 Global IV Administration Primary Set Sales Value by Application (2020 VS 2024 VS 2031) 4.2.2 Global IV Administration Primary Set Sales Value, by Application (2020-2031) 4.2.3 Global IV Administration Primary Set Sales Value, by Application (%) (2020-2031) 4.3 Global IV Administration Primary Set Sales Volume by Application 4.3.1 Global IV Administration Primary Set Sales Volume by Application (2020 VS 2024 VS 2031) 4.3.2 Global IV Administration Primary Set Sales Volume, by Application (2020-2031) 4.3.3 Global IV Administration Primary Set Sales Volume, by Application (%) (2020-2031) 4.4 Global IV Administration Primary Set Average Price by Application (2020-2031) 5 Segmentation by Region 5.1 Global IV Administration Primary Set Sales Value by Region 5.1.1 Global IV Administration Primary Set Sales Value by Region: 2020 VS 2024 VS 2031 5.1.2 Global IV Administration Primary Set Sales Value by Region (2020-2025) 5.1.3 Global IV Administration Primary Set Sales Value by Region (2026-2031) 5.1.4 Global IV Administration Primary Set Sales Value by Region (%), (2020-2031) 5.2 Global IV Administration Primary Set Sales Volume by Region 5.2.1 Global IV Administration Primary Set Sales Volume by Region: 2020 VS 2024 VS 2031 5.2.2 Global IV Administration Primary Set Sales Volume by Region (2020-2025) 5.2.3 Global IV Administration Primary Set Sales Volume by Region (2026-2031) 5.2.4 Global IV Administration Primary Set Sales Volume by Region (%), (2020-2031) 5.3 Global IV Administration Primary Set Average Price by Region (2020-2031) 5.4 North America 5.4.1 North America IV Administration Primary Set Sales Value, 2020-2031 5.4.2 North America IV Administration Primary Set Sales Value by Country (%), 2024 VS 2031 5.5 Europe 5.5.1 Europe IV Administration Primary Set Sales Value, 2020-2031 5.5.2 Europe IV Administration Primary Set Sales Value by Country (%), 2024 VS 2031 5.6 Asia Pacific 5.6.1 Asia Pacific IV Administration Primary Set Sales Value, 2020-2031 5.6.2 Asia Pacific IV Administration Primary Set Sales Value by Region (%), 2024 VS 2031 5.7 South America 5.7.1 South America IV Administration Primary Set Sales Value, 2020-2031 5.7.2 South America IV Administration Primary Set Sales Value by Country (%), 2024 VS 2031 5.8 Middle East & Africa 5.8.1 Middle East & Africa IV Administration Primary Set Sales Value, 2020-2031 5.8.2 Middle East & Africa IV Administration Primary Set Sales Value by Country (%), 2024 VS 2031 6 Segmentation by Key Countries/Regions 6.1 Key Countries/Regions IV Administration Primary Set Sales Value Growth Trends, 2020 VS 2024 VS 2031 6.2 Key Countries/Regions IV Administration Primary Set Sales Value 6.2.1 Key Countries/Regions IV Administration Primary Set Sales Value, 2020-2031 6.2.2 Key Countries/Regions IV Administration Primary Set Sales Volume, 2020-2031 6.3 United States 6.3.1 United States IV Administration Primary Set Sales Value, 2020-2031 6.3.2 United States IV Administration Primary Set Sales Value by Type (%), 2024 VS 2031 6.3.3 United States IV Administration Primary Set Sales Value by Application, 2024 VS 2031 6.4 Europe 6.4.1 Europe IV Administration Primary Set Sales Value, 2020-2031 6.4.2 Europe IV Administration Primary Set Sales Value by Type (%), 2024 VS 2031 6.4.3 Europe IV Administration Primary Set Sales Value by Application, 2024 VS 2031 6.5 China 6.5.1 China IV Administration Primary Set Sales Value, 2020-2031 6.5.2 China IV Administration Primary Set Sales Value by Type (%), 2024 VS 2031 6.5.3 China IV Administration Primary Set Sales Value by Application, 2024 VS 2031 6.6 Japan 6.6.1 Japan IV Administration Primary Set Sales Value, 2020-2031 6.6.2 Japan IV Administration Primary Set Sales Value by Type (%), 2024 VS 2031 6.6.3 Japan IV Administration Primary Set Sales Value by Application, 2024 VS 2031 6.7 South Korea 6.7.1 South Korea IV Administration Primary Set Sales Value, 2020-2031 6.7.2 South Korea IV Administration Primary Set Sales Value by Type (%), 2024 VS 2031 6.7.3 South Korea IV Administration Primary Set Sales Value by Application, 2024 VS 2031 6.8 Southeast Asia 6.8.1 Southeast Asia IV Administration Primary Set Sales Value, 2020-2031 6.8.2 Southeast Asia IV Administration Primary Set Sales Value by Type (%), 2024 VS 2031 6.8.3 Southeast Asia IV Administration Primary Set Sales Value by Application, 2024 VS 2031 6.9 India 6.9.1 India IV Administration Primary Set Sales Value, 2020-2031 6.9.2 India IV Administration Primary Set Sales Value by Type (%), 2024 VS 2031 6.9.3 India IV Administration Primary Set Sales Value by Application, 2024 VS 2031 7 Company Profiles 7.1 BD 7.1.1 BD Company Information 7.1.2 BD Introduction and Business Overview 7.1.3 BD IV Administration Primary Set Sales, Revenue, Price and Gross Margin (2020-2025) 7.1.4 BD IV Administration Primary Set Product Offerings 7.1.5 BD Recent Development 7.2 B. Braun 7.2.1 B. Braun Company Information 7.2.2 B. Braun Introduction and Business Overview 7.2.3 B. Braun IV Administration Primary Set Sales, Revenue, Price and Gross Margin (2020-2025) 7.2.4 B. Braun IV Administration Primary Set Product Offerings 7.2.5 B. Braun Recent Development 7.3 Amsino 7.3.1 Amsino Company Information 7.3.2 Amsino Introduction and Business Overview 7.3.3 Amsino IV Administration Primary Set Sales, Revenue, Price and Gross Margin (2020-2025) 7.3.4 Amsino IV Administration Primary Set Product Offerings 7.3.5 Amsino Recent Development 7.4 3M 7.4.1 3M Company Information 7.4.2 3M Introduction and Business Overview 7.4.3 3M IV Administration Primary Set Sales, Revenue, Price and Gross Margin (2020-2025) 7.4.4 3M IV Administration Primary Set Product Offerings 7.4.5 3M Recent Development 7.5 Baxter International 7.5.1 Baxter International Company Information 7.5.2 Baxter International Introduction and Business Overview 7.5.3 Baxter International IV Administration Primary Set Sales, Revenue, Price and Gross Margin (2020-2025) 7.5.4 Baxter International IV Administration Primary Set Product Offerings 7.5.5 Baxter International Recent Development 7.6 ICU Medical 7.6.1 ICU Medical Company Information 7.6.2 ICU Medical Introduction and Business Overview 7.6.3 ICU Medical IV Administration Primary Set Sales, Revenue, Price and Gross Margin (2020-2025) 7.6.4 ICU Medical IV Administration Primary Set Product Offerings 7.6.5 ICU Medical Recent Development 7.7 Smiths Medical 7.7.1 Smiths Medical Company Information 7.7.2 Smiths Medical Introduction and Business Overview 7.7.3 Smiths Medical IV Administration Primary Set Sales, Revenue, Price and Gross Margin (2020-2025) 7.7.4 Smiths Medical IV Administration Primary Set Product Offerings 7.7.5 Smiths Medical Recent Development 7.8 Bayer 7.8.1 Bayer Company Information 7.8.2 Bayer Introduction and Business Overview 7.8.3 Bayer IV Administration Primary Set Sales, Revenue, Price and Gross Margin (2020-2025) 7.8.4 Bayer IV Administration Primary Set Product Offerings 7.8.5 Bayer Recent Development 7.9 Zyno Medical 7.9.1 Zyno Medical Company Information 7.9.2 Zyno Medical Introduction and Business Overview 7.9.3 Zyno Medical IV Administration Primary Set Sales, Revenue, Price and Gross Margin (2020-2025) 7.9.4 Zyno Medical IV Administration Primary Set Product Offerings 7.9.5 Zyno Medical Recent Development 7.10 Advanced Medical Systems 7.10.1 Advanced Medical Systems Company Information 7.10.2 Advanced Medical Systems Introduction and Business Overview 7.10.3 Advanced Medical Systems IV Administration Primary Set Sales, Revenue, Price and Gross Margin (2020-2025) 7.10.4 Advanced Medical Systems IV Administration Primary Set Product Offerings 7.10.5 Advanced Medical Systems Recent Development 7.11 MPS Medical 7.11.1 MPS Medical Company Information 7.11.2 MPS Medical Introduction and Business Overview 7.11.3 MPS Medical IV Administration Primary Set Sales, Revenue, Price and Gross Margin (2020-2025) 7.11.4 MPS Medical IV Administration Primary Set Product Offerings 7.11.5 MPS Medical Recent Development 7.12 SB Kawasumi 7.12.1 SB Kawasumi Company Information 7.12.2 SB Kawasumi Introduction and Business Overview 7.12.3 SB Kawasumi IV Administration Primary Set Sales, Revenue, Price and Gross Margin (2020-2025) 7.12.4 SB Kawasumi IV Administration Primary Set Product Offerings 7.12.5 SB Kawasumi Recent Development 7.13 MedSource Labs 7.13.1 MedSource Labs Company Information 7.13.2 MedSource Labs Introduction and Business Overview 7.13.3 MedSource Labs IV Administration Primary Set Sales, Revenue, Price and Gross Margin (2020-2025) 7.13.4 MedSource Labs IV Administration Primary Set Product Offerings 7.13.5 MedSource Labs Recent Development 7.14 Eitan Group 7.14.1 Eitan Group Company Information 7.14.2 Eitan Group Introduction and Business Overview 7.14.3 Eitan Group IV Administration Primary Set Sales, Revenue, Price and Gross Margin (2020-2025) 7.14.4 Eitan Group IV Administration Primary Set Product Offerings 7.14.5 Eitan Group Recent Development 7.15 CODAN US Corporation 7.15.1 CODAN US Corporation Company Information 7.15.2 CODAN US Corporation Introduction and Business Overview 7.15.3 CODAN US Corporation IV Administration Primary Set Sales, Revenue, Price and Gross Margin (2020-2025) 7.15.4 CODAN US Corporation IV Administration Primary Set Product Offerings 7.15.5 CODAN US Corporation Recent Development 7.16 Medtec Medical 7.16.1 Medtec Medical Company Information 7.16.2 Medtec Medical Introduction and Business Overview 7.16.3 Medtec Medical IV Administration Primary Set Sales, Revenue, Price and Gross Margin (2020-2025) 7.16.4 Medtec Medical IV Administration Primary Set Product Offerings 7.16.5 Medtec Medical Recent Development 8 Industry Chain Analysis 8.1 IV Administration Primary Set Industrial Chain 8.2 IV Administration Primary Set Upstream Analysis 8.2.1 Key Raw Materials 8.2.2 Raw Materials Key Suppliers 8.2.3 Manufacturing Cost Structure 8.3 Midstream Analysis 8.4 Downstream Analysis (Customers Analysis) 8.5 Sales Model and Sales Channels 8.5.1 IV Administration Primary Set Sales Model 8.5.2 Sales Channel 8.5.3 IV Administration Primary Set Distributors 9 Research Findings and Conclusion 10 Appendix 10.1 Research Methodology 10.1.1 Methodology/Research Approach 10.1.1.1 Research Programs/Design 10.1.1.2 Market Size Estimation 10.1.1.3 Market Breakdown and Data Triangulation 10.1.2 Data Source 10.1.2.1 Secondary Sources 10.1.2.2 Primary Sources 10.2 Author Details 10.3 Disclaimer
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野（医療機器）の最新刊レポート
QYResearch社の医療機器・消耗品分野での最新刊レポート
本レポートと同じKEY WORD（administration）の最新刊レポート
よくあるご質問QYResearch社はどのような調査会社ですか?QYリサーチ(QYResearch)は幅広い市場を対象に調査・レポート出版を行う、中国に本社をおく調査会社です。 QYResearchでは年間数百タイトルの調査レポートを出版しています。... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
